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II. PROJECT OBJECTIVES:
The goal of this study is to analyze the relationship between immune function,
infectious illness symptoms, premenstrual distress, and menstrual cycle stage in collegeaged non-pregnant females. The menstrual cycle is divided into three phases: follicular,
ovulatory, and luteal. Prior research also indicates changes in immune function during the
phases of the cycle. During the ovulatory phase, IL-6, IL-8, and IL-l beta are
differentially regulated (AI-Harthi et aI., 2000). According to Agarwal and Marshall, the

type-l/type-2 cytokine balance is also affected near the time of menstruation as
evidenced by a shift toward type-2 cytokines (1999). In a study of disease processes
during the phases of the menstrual cycle, Lee, Bazar, and Yun postulated that the shift in
immunity that they found involving Th-l and Th-2 is due to autonomic balance (2004).
One study found a direct relationship between the secretion of estradiol and the secretion
oflgA by the parotid gland (Gomez et at, 1993). Groer et al (1993) found a relationship
between menstrual cycle stage, menstrual cycle distress, and symptoms of infection in
college-aged women. Studies have also shown a relationship between premenstrual
syndrome (PMS) and hormone function that may affect immunity. Odber, Cawood, and
Bancroft found that, unlike major depression where the underlying neurological changes
are manifested as overactivity of the HP A axis, premenstrual depressive changes are
associated with reduced HP A activity. Premenstrual depression may, therefore, be similar
neurologically to seasonal affective disorder, which is associated with underactivity of
the HP A axis (1998). Women with PMS in a study by Cornwell had "significantly higher
mean levels of plasma cortisol" and differences in estradiol (2000). These findings
support our study of cycle phase, premenstrual distress, and immune and infection
variables.

III. DESCRIPTION AND SOURCE OF RESEARCH PARTICIPANTS:
The proposed study involves the formation of a voluntary sample based upon the
following criteria: women aged between eighteen and thirty-five, weighing 110 pounds or
more, non-pregnant, regularly menstruating with a 27-31 day cycle, able to speak and
understand English, and willing and able to donate a blood sample of approximately 10
milliliters by venipuncture one time. Data collection will be between 8 and 9 am.
The participants will be informed of the study by flyers distributed to various UT
campus organizations and UT campus bulletin boards. Estimated sample size is 100
women, evenly distributed across the three menstrual cycle stages with at least 30
participants per stage. Stage will be determined by date of last menstrual period. If the
distribution of subjects by stage becomes skewed, volunteers will be asked to return for
testing during a specific menstrual cycle stage.
IV. METHODS AND PROCEDURES
The blood will be analyzed for the following: ex vivo cytokine production,
lymphocyte proliferation, serum levels oflLI0 and Interferon-gamma, prolactin, cortisol,
and ACTH. The statistical analysis will consist of correlations and regressions analyzing
the relationships between distress and immune variables, and ANOV As analyzing
relationships between stage and immune variables.
V. SPECIFIC RISKS AND PROTECTION MEASURES
The foreseeable physical risks involved in this project are those normally
involved with venipuncture, including pain, nausea, syncope, bruising. The foreseeable
psychological risks include fear of venipuncture. Approval from The University of
Tennessee's IRB will be sought and obtained before any subject is questioned or samples
of blood are collected. Because the proposed study will involve human subjects, the
researchers will take all possible precautions to ensure their protection. Racial and ethnic
groups will be treated equally; all subjects will receive the same explanation of the

research purpose and procedures, the same c?~sent fo~, and hav~ access to the s~~
support throughout the research period. PartIcIpants WIll be fully l~formed of theIr nghts
as participants and of the procedures involved in the research. Wntten consent to
.
participate will be obtained from all participant~.
Only after participants have received wntten and oral explanatIOns of the study,
any questions about the study have been answered, and written consent to participate in
the study has been obtained will any questionnaires be administered or blood samples be
drawn. Each participant will be assigned a number which will be used to identify their
data and will be in no way tied to their actual identity. Completed surveys will be kept in
a locked file cabinet in Room 345 of the College of Nursing.

VI. BENEFITS
There is the benefit to subjects of receiving information regarding their current
immune function. Any values outside the range of normal will be reported to subjects for
follow-up with their health care provider. This will be done by posting results by ID
number on Dr. Groer's website. There is a benefit to science of determining any
relationships between menstrual cycle, PMS, and immunity and infection.
VII. METHODS FOR OBTAINING "INFORMED CONSENT" FROM
P ARTICIPANTS
The study will be described orally and in writing to those who volunteer to
participate in the study before they will be asked to sign the informed consent document.
The research will be described as a study created to compare the relationship between
immune function, menstrual cycle, and premenstrual syndrome. All description and
explanation of the research will be provided in simple language and potential participants
will have ample opportunity to ask questions of the investigators. The consent document
will contain all basic elements of informed consent and a copy will be provided for the
participants' use and information.
VIII. QUALIFICATIONS OF THE INVESTIGATORS
Emma Taylor and Rachel Hodges are undergraduate senior nursing student and
the College of Nursing at the University of Tennessee. Both have completed the National
Institute of Health (NIH) training module for the protection of human subjects. Both
primary investigators have been trained in venipuncture procedures.
Maureen Groer has a PhD in physiology and biophysics and is a professor of
Nursing. She manages the Kenneth Walker Nursing Science laboratory. She is competent
in human subjects research and laboratory methodology.
IX. FACILITIES AND EQUIPMENT TO BE USED IN THE RESEARCH
Recruitment will take place by flyers posted around the University of Tennessee
campus. The Kenneth Walker Nursing Science lab will be the site for much of the data
analysis. The equipment in this lab is standard laboratory equipment for preparing serum
samples and cell cultures.
X. RESPONSIBILITY OF THE PRINCIPAL INVESTIGATORS

By compliance with the policies established by the Institutional Review Board of
The University of Tennessee, the principal investigators subscribe to the principles stated
in the "Belmont Report" and standards of professional ethics in research, development,
and related activities involving human participants under the auspices of The University
of Tennessee. The principal investigators further agree that:
1) Approval will be obtained from the Institutional Review Board prior to instituting
any change in this research project.
2) Development of any unexpected risks will be immediately reported to the
Research Compliance Services section.
3) Signed informed consent documents will be kept for the duration of the project
and for at least three years thereafter in a location approved by the Institutional
Review Board.
XI. SIGNATURES
Principal Investigator

Rachel M. Hodges
(name)

Signature
(date)
Principal Investigator

Emma L. Taylor
(name)

Signature
(date)
Faculty Advisor

Maureen Groer 2 PhD
(name)

Signature
(date)

Informed Consent Statement
Relationship between Immune Function and Menstrual Cycle Stage
INTRODUCTION
You are invited to participate in a research study designed to analyze relationships
between immunity, menstruation, and premenstrual syndrome.

INFORMATION ABOUT PARTICIPANTS' INVOLVEMENT IN THE STUDY
As a subject of our study, you will answer a questionnaire for demographic information
and another on premenstrual symptoms you had before your last menstrual period. You
will then have blood drawn in the lab, which will be analyzed for immune markers.
The questionnaires will take approximately thirty minutes to complete, and the blood
draw will take approximately fifteen minutes. We will be collecting blood samples
during early to mid-January 2005.

RISKS
The possible foreseeable risks to you in this study include fear of having blood drawn,
reliving painful memories brought up by the PMS questionnaire, mild pain during blood
collection, bruising, nausea, fainting, and rarely hematoma (a bruise under the skin).

BENEFITS
There is the benefit to you of receiving information regarding your current immune
function. You will potentially benefit from receiving information about significant
findings of the study. There is a benefit to science of determining any relationships
between menstrual cycle, PMS, and the immune system if any are found.

CONFIDENTIALITY
The information in the study records will be kept confidential. Data will be stored
securely and will be made available only to persons conducting the study unless
participants specifically give permission in writing to do otherwise. No reference will be
made in oral or written reports which could link participants to the study.

Participant's initials __

EMERGENCY MEDICAL TREATMENT

The University of Tennessee does not "automatically" reimburse participants for medical
claims. If physical injury is suffered in the course of research, please notify the
investigators:
Emma Taylor

Rachel M. Hodges

Etaylor5@utk.edu

rmorris6@utk.ed

Dr. Maureen Groer

(865)974-7615
mgroer@utkedu

CONTACT INFORMATION

If you have questions at any time about the study or the procedures (or experience
adverse effects), you may contact the researchers, Emma Taylor or Rachel M. Hodges at
etaylor5@utkedu or rmorris6@utkedu respectively. If you have questions about your
rights as a participant, contact the Compliance Section of the Office of Research at
(865)974-3466.
PARTICIPATION

Your participation in this study is voluntary, and you may decline to participate without
penalty. If you decide to participate, you may withdraw from the study at anytime
without penalty and without loss of benefits to which you are otherwise entitled. If you
withdraw from the study before data collection is completed your data will be returned to
you or destroyed.

CONSENT
I have read the above information. I have received a copy of this form. I agree to
participate in this study.
Participant's Signature _ _ _ _ _ _ _ _ _ _ __

Date- - - - -

Investigator's Signature _ _ _ _ _ _ _ _ _ _ __

Date_ _ _ __

Rachel M. Hodges and Emma Taylor (Maureen Groer, advisor)
Relationships between Immunity, Infection, and Menstrual Cycle Stage
Abstract
This research study is designed to analyze relationships between immunity, stages
of the menstrual cycle, and premenstrual syndrome in college-aged, non-pregnant

females. Previous studies have suggested a link between the immune system and the
menstrual cycle. A better understanding of this relationship may aid in interpretation of
the reproductive cycle and conception. The study was approved by the UT IRB. The
participants, who were informed of the study by flyers, completed questionnaires for
demographic information and premenstrual symptoms, and a blood sample was drawn in
the lab. The analysis will compare cellular and humoral immune marker levels, menstrual
cycle stage, and subjective responses to the premenstrual distress questionnaire and
examine relationships among the variables.

Have you ever wondered what your immune
system is doing during your menstrual
cycle?
If you have, then come participate in our research
study. We will draw a sample of your blood and test for
specific immune cells in it. To participate in the study
you need to be female who weighs at least 110 Ibs and
is between the ages of eighteen and thirty-five. If you
are interested please contact any of the following:
Rachel M. Hodges
Rmorris6@utk.edu

Emma Taylor
etaylor5@utk.edu
Dr. Maureen Groer
345 College of Nursing
Knoxville, TN 37996

(865)974-7615
mgroer@utk.edu

OATE:____

10#"_ _ _ _ __

LAST MENSTRUAL PERIOD MODULE
1. On what date did your last period begin?

_1_1-

2. How long was your most recent full menstrual cycle (starting from the first day of your period
to the day before you started your next period; average 24-35 days)? # DAYS:

Did these feelings
cease by the end (
your period or
shortly thereafter?
(check YES or NO;

How much did you experience each of these symptoms
during the week BEFORE your last period?

1. Did you feel depressed, sad,
down or blue?
2. Did you feel hopeless?
3. Did you feel worthless or
guilty?

4. Did you feel anxious, tense,
keyed up or on edge?
5. Did you have mood swings,
such as feeling suddenly sad or
tearful?
6. Were you more sensitive to
rejection; were your feelings
easily hurt?
7. Did you feel angry or irritable?
8. Did you have conflicts or
problems with people?
9. Did you have less interest in
usual activities (i.e. work, school,
friends, hobbies)?
10. Did you have difficulty
concentrating?
11. Did you feel lethargic, tired,
fatigued or have lack of energy?
12. Did you have increased
appetite or overeat?

Not at all

Minimal

(1)

(2)

Mild

Moderate

Severe

Extreme

(3)

(4)

(5)

(6)

YES

NO

Did these feelings
cease by the end (
your period or
shortly thereafter?
(check YES or NO'

How much did you experience each of these symptoms
during the week BEFORE your last period?
Not at all

Minimal

Mild

Moderate

Severe

Extreme

(1)

(2)

(3)

(4)

(5)

(6)

13. Did you have cravings for
specific foods?
14. Did you sleep more, take naps, or
find it hard to get up when you
intend?
15. Did you have trouble getting to
sleep or staying asleep?
16. Did you feel overwhelmed or that
you could not cope?
17. Did you feel out of control?
18. Did you have breast tenderness?
19. Did you have breast swelling, feel
bloated or have weight gain?
20. Did you have a headache?
21. Did you have joint or muscle
pain?

A. At work, at school, at home or in
daily routine, did at least one of the
problems noted above cause
reduction in productivity or
inefficiency?
B. Did at least one of the problems
noted above interfere with hobbies or
social activities, such that you
avoided or did less?

C. Did at least one of the problems
noted above interfere with
relationships with others?
NEVER

D. During the 6-7 days before your
period, to what extent did you feel too
exhausted to do your work?
E. During the 6-7 days before your
period, to what extent did you
become restless while working?

RARELY

SOMETIMES

OFTEN

ALMOST
ALWAYS

YES

N(

Relationships between Immune Function and Menstrual Cycle Stage
Introduction
You are invited to participate in a research study looking for relationships between the
immune function and menstrual cycles and premenstrual symptoms of nonpregnant
women.
Information about Participants' Involvement in the Study
As a subject of our study, you will answer a questionnaire for demographic information
and another on premenstrual symptoms you had before your last menstrual period. You
will then have blood drawn in the lab, which will be analyzed for immune markers.
The questionnaires will take approximately thirty minutes to complete, and the blood
draw will take approximately fifteen minutes. We will be collecting blood samples
during early to mid-January 2005.
Risks
The possible foreseeable risks to you in this study include fear of having blood drawn,
reliving painful memories brought up by the PMS questionnaire, mild pain during blood
collection, bruising, nausea, fainting, and rarely hematoma (a bruise under the skin).
Benefits
There is the benefit to you of receiving information regarding your current immune
function. You will potentially benefit from receiving information about significant
findings of the study. There is a benefit to science of determining any relationships
between menstrual cycle, PMS, and the immune system if any are found.
Confidentiality
The information in the study records will be kept confidential. Data will be stored
securely and will be made available only to persons conducting the study unless
participants specifically give permission in writing to do otherwise. No reference will be
made in oral or written reports which could link participants to the study.
Contact
If you have questions at any time about the study or the procedures, you may contact the
researchers, Emma Taylor or Rachel M. Hodges at etaylor5@utk.edu or
rmorris6@utk.edu respectively. If you have questions about your rights as a participant,
contact the Compliance Section of the Office of Research at (865)974-3466.
Participation

Your participation in this study is voluntary, and you may decline to participate without
penalty. If you decide to participate, you may withdraw from the study at anytime
without penalty and without loss of benefits to which you are otherwise entitled. If you
withdraw from the study before data collection is completed your data will be returned to
you or destroyed.

Lit Review
The menstrual cycle is divided into three phases: follicular, ovulatory, and luteal.
Prior research also indicates changes in immune function during the phases of the cycle.
During the ovulatory phase, IL-6, IL-8, and IL-l beta are differentially regulated (AIHarthi et aI., 2000). According to Agarwal and Marshall, the type-l/type-2 cytokine
balance is also affected near the time of menstruation as evidenced by a shift toward
type-2 cytokines (1999). In a study of disease processes during the phases of the
menstrual cycle, Lee, Bazar, and Yun postulated that the shift in immunity that they
found involving Th-1 and Th-2 is due to autonomic balance (2004). One study found a
direct relationship between the secretion of estradiol and the secretion of IgA by the
parotid gland (Gomez et aI., 1993).
Studies have also shown a relationship between premenstrual syndrome (PMS)
and hormone function that may affect immunity. Odber, Cawood, and Bancroft found
that
unlike major depression where the underlying neurological changes are
manifest[ ed] as overactivity ofthe HPA axis, premenstrual depressive changes
are associated with reduced HP A axis activity. Premenstrual depression may,
therefore, be similar neurologically to seasonal affective disorder, which is
associated with underactivity of the HPA axis (1998).
Women with PMS in a study by Cornwell had "significantly higher mean levels of
plasma cortisol" and differences in estradiol (2000). We think these findings are
significant in the study of correlations between PMS and immune function.
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American Journal of Reproductive Immunology, 29(4), 219-23.
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may be a factor in exacerbations of certain diseases during the menstrual cycle.
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Participation
Under the supervision of Dr. Groer, we prepared the attached documents to seek
IRB approval for the research study. After gaining IRB approval, flyers were hung on

campus to recruit subjects. Once testing began, we were present in the lab for four weeks
from Monday through Thursday, 3 pm until 7 pm, and Friday afternoon for
approximately two hours. We instructed participants to respond to the questionnaires,
then answered any questions they had concerning the study. We drew their blood,
prepared it, incubated it, and froze it in order to do the assays at a later date. However, the
plate reader in the Kenneth Walker Nursing Science laboratory has been sent off for
repair and we are currently unable to obtain results. We plan on participating in the
research further after graduation.

